RPG Life Sciences Ltd.
BSE: 532983 | Sector: Health care |
NSE: RPGLIFE | ISIN Code: INE105J01010 |
BSE 00:00 | 25 Feb | 416.25 |
-2.50 (-0.60%) |
OPEN
418.75 |
HIGH
420.05 |
LOW
408.05 |
NSE 00:00 | 25 Feb | 416.20 |
-0.95 (-0.23%) |
OPEN
415.90 |
HIGH
421.30 |
LOW
415.75 |
OPEN | 418.75 |
PREVIOUS CLOSE | 418.75 |
VOLUME | 3195 |
52-Week high | 456.10 |
52-Week low | 146.00 |
P/E | 17.07 |
Mkt Cap.(Rs cr) | 688 |
Buy Price | 415.00 |
Buy Qty | 19.00 |
Sell Price | 425.00 |
Sell Qty | 125.00 |
About RPG Life Sciences Ltd.
RPG Life Sciences Ltd is engaged in the development manufacture and marketing of bulk drugs and formulations primarily in India. The company provides active pharmaceutical ingredients and generic formulations as well as medications for critical and chronic ailments. They also manufacture life saving drugs using biotechnology.The company is having research and development facilities that conform to...> More
RPG Life Sciences Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
688 | |
EPS - TTM | (![]() |
[*S] | 24.38 |
P/E Ratio | (X) | [*S] | 17.07 |
Face Value | (![]() |
8 | |
Latest Dividend | (%) | 50.00 | |
Latest Dividend Date | 24 Mar 2020 | ||
Dividend Yield | (%) | 0.96 | |
Book Value / Share | (![]() |
[*S] | 118.93 |
P/B Ratio | (![]() |
[*S] | 3.50 |
Announcement
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Announcement under Regulation 30 (LODR)-Change in Directorate
-
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
-
Unaudited Financial Results For Quarter Ended December 31 2020
RPG Life Sciences Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | 107.6 | 94.37 | 14.02 |
Other Income | 0.12 | 0.04 | 200 |
Total Income | 107.72 | 94.41 | 14.1 |
Total Expenses | 86.3 | 79.48 | 8.58 |
Operating Profit | 21.42 | 14.93 | 43.47 |
Net Profit | 12.87 | 7.91 | 62.71 |
Equity Capital | 13.23 | 13.23 | - |
RPG Life Sciences Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Fermenta Biotec. | 284.70 | 7.72 | 838.16 |
TTK Healthcare | 568.30 | 1.43 | 803.01 |
Medicamen Biotec | 613.00 | 1.89 | 749.09 |
RPG LifeScience. | 416.25 | -0.60 | 688.37 |
Bajaj Healthcare | 468.65 | 0.93 | 646.74 |
Anuh Pharma | 110.75 | 0.64 | 555.08 |
Kopran | 122.10 | -1.13 | 528.08 |
RPG Life Sciences Ltd - SHAREHOLDING PATTERN
|
|
RPG Life Sciences Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -1.25% | -1.82% | -0.56% | -0.73% |
1 Month | -1.98% | -6.22% | 5.57% | 5.05% |
3 Month | 16.66% | 13.01% | 16.45% | 15.64% |
6 Month | 8.23% | 6.39% | 31.40% | 31.67% |
1 Year | 53.40% | 48.99% | 26.71% | 27.63% |
3 Year | -7.99% | -7.93% | 49.49% | 43.91% |
RPG Life Sciences Ltd - STOCK STRENGTH
Today's Low/High | 408.05 | 420.05 | |
Week Low/High | 403.00 | 438.00 | |
Month Low/High | 389.10 | 456.00 | |
YEAR Low/High | 146.00 | 456.00 | |
All TIME Low/High | 17.10 | 606.00 |
Quick Links for RPG Life Sciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices